Drug Shortage Report for TARO-RISPERIDONE
| Report ID | 199143 |
| Drug Identification Number | 02328305 |
| Brand name | TARO-RISPERIDONE |
| Common or Proper name | RISPERIDONE |
| Company Name | SUN PHARMA CANADA INC |
| Market Status | DORMANT |
| Active Ingredient(s) | RISPERIDONE |
| Strength(s) | 0.25MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N05AX |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-01-01 |
| Estimated end date | 2023-10-15 |
| Actual end date | 2023-09-15 |
| Shortage status | Resolved |
| Updated date | 2023-09-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2023-09-22 | French | Compare |
| v9 | 2023-09-22 | English | Compare |
| v8 | 2023-09-22 | French | Compare |
| v7 | 2023-09-22 | English | Compare |
| v6 | 2023-08-30 | French | Compare |
| v5 | 2023-08-30 | English | Compare |
| v4 | 2023-08-16 | French | Compare |
| v3 | 2023-08-16 | English | Compare |
| v2 | 2023-07-18 | French | Compare |
| v1 | 2023-07-18 | English | Compare |
Showing 1 to 10 of 10